FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308354355> ?p ?o ?g. }

• W4308354355 abstract "Abstract Background Glioblastoma (GBM), the most common glial primary brain tumour, is without exception lethal. Every year approximately 600 patients are diagnosed with this heterogeneous disease in The Netherlands. Despite neurosurgery, chemo -and radiation therapy, these tumours inevitably recur. Currently, there is no gold standard at time of recurrence and treatment options are limited. Unfortunately, the results of dedicated trials with new drugs have been very disappointing. The goal of the project is to obtain the evidence for changing standard of care (SOC) procedures to include whole genome sequencing (WGS) and consequently adapt care guidelines for this specific patient group with very poor prognosis by offering optimal and timely benefit from novel therapies, even in the absence of traditional registration trials for this small volume cancer indication. Methods The GLOW study is a prospective diagnostic cohort study executed through collaboration of the Hartwig Medical Foundation (Hartwig, a non-profit organisation) and twelve Dutch centers that perform neurosurgery and/or treat GBM patients. A total of 200 patients with a first recurrence of a glioblastoma will be included. Dual primary endpoint is the percentage of patients who receive targeted therapy based on the WGS report and overall survival. Secondary endpoints include WGS report success rate and number of targeted treatments available based on WGS reports and number of patients starting a treatment in presence of an actionable variant. At recurrence, study participants will undergo SOC neurosurgical resection. Tumour material will then, together with a blood sample, be sent to Hartwig where it will be analysed by WGS. A diagnostic report with therapy guidance, including potential matching off-label drugs and available clinical trials will then be sent back to the treating physician for discussing of the results in molecular tumour boards and targeted treatment decision making. Discussion The GLOW study aims to provide the scientific evidence for changing the SOC diagnostics for patients with a recurrent glioblastoma by investigating complete genome diagnostics to maximize treatment options for this patient group. Trial registration: ClinicalTrials.gov Identifier: NCT05186064." @default.
• W4308354355 created "2022-11-11" @default.
• W4308354355 creator A5001441278 @default.
• W4308354355 creator A5004901028 @default.
• W4308354355 creator A5013779863 @default.
• W4308354355 creator A5015994964 @default.
• W4308354355 creator A5018771146 @default.
• W4308354355 creator A5025654942 @default.
• W4308354355 creator A5033587548 @default.
• W4308354355 creator A5041487312 @default.
• W4308354355 creator A5047802794 @default.
• W4308354355 creator A5049325070 @default.
• W4308354355 creator A5049513985 @default.
• W4308354355 creator A5063693691 @default.
• W4308354355 creator A5067476155 @default.
• W4308354355 creator A5072084304 @default.
• W4308354355 creator A5082248372 @default.
• W4308354355 creator A5085953690 @default.
• W4308354355 creator A5086259606 @default.
• W4308354355 creator A5089011342 @default.
• W4308354355 date "2022-11-04" @default.
• W4308354355 modified "2023-10-01" @default.
• W4308354355 title "Study protocol of the GLOW study: maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnostics—a prospective multicenter cohort study" @default.
• W4308354355 cites W1571317512 @default.
• W4308354355 cites W2013827712 @default.
• W4308354355 cites W2044538065 @default.
• W4308354355 cites W2051978340 @default.
• W4308354355 cites W2052491055 @default.
• W4308354355 cites W2096287682 @default.
• W4308354355 cites W2098771215 @default.
• W4308354355 cites W2103630928 @default.
• W4308354355 cites W2104352635 @default.
• W4308354355 cites W2123808042 @default.
• W4308354355 cites W2127745545 @default.
• W4308354355 cites W2132697290 @default.
• W4308354355 cites W2147806499 @default.
• W4308354355 cites W2148923175 @default.
• W4308354355 cites W2149594980 @default.
• W4308354355 cites W2158681922 @default.
• W4308354355 cites W2165871546 @default.
• W4308354355 cites W2768388636 @default.
• W4308354355 cites W2888034354 @default.
• W4308354355 cites W2888616775 @default.
• W4308354355 cites W2914199948 @default.
• W4308354355 cites W2973085389 @default.
• W4308354355 cites W2976525441 @default.
• W4308354355 cites W2981548686 @default.
• W4308354355 cites W3017098684 @default.
• W4308354355 cites W3023279101 @default.
• W4308354355 cites W3098623230 @default.
• W4308354355 cites W3128713567 @default.
• W4308354355 cites W3157522626 @default.
• W4308354355 cites W3198806745 @default.
• W4308354355 doi "https://doi.org/10.1186/s12920-022-01343-4" @default.
• W4308354355 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36333718" @default.
• W4308354355 hasPublicationYear "2022" @default.
• W4308354355 type Work @default.
• W4308354355 citedByCount "0" @default.
• W4308354355 crossrefType "journal-article" @default.
• W4308354355 hasAuthorship W4308354355A5001441278 @default.
• W4308354355 hasAuthorship W4308354355A5004901028 @default.
• W4308354355 hasAuthorship W4308354355A5013779863 @default.
• W4308354355 hasAuthorship W4308354355A5015994964 @default.
• W4308354355 hasAuthorship W4308354355A5018771146 @default.
• W4308354355 hasAuthorship W4308354355A5025654942 @default.
• W4308354355 hasAuthorship W4308354355A5033587548 @default.
• W4308354355 hasAuthorship W4308354355A5041487312 @default.
• W4308354355 hasAuthorship W4308354355A5047802794 @default.
• W4308354355 hasAuthorship W4308354355A5049325070 @default.
• W4308354355 hasAuthorship W4308354355A5049513985 @default.
• W4308354355 hasAuthorship W4308354355A5063693691 @default.
• W4308354355 hasAuthorship W4308354355A5067476155 @default.
• W4308354355 hasAuthorship W4308354355A5072084304 @default.
• W4308354355 hasAuthorship W4308354355A5082248372 @default.
• W4308354355 hasAuthorship W4308354355A5085953690 @default.
• W4308354355 hasAuthorship W4308354355A5086259606 @default.
• W4308354355 hasAuthorship W4308354355A5089011342 @default.
• W4308354355 hasBestOaLocation W43083543551 @default.
• W4308354355 hasConcept C126322002 @default.
• W4308354355 hasConcept C12770488 @default.
• W4308354355 hasConcept C141071460 @default.
• W4308354355 hasConcept C143998085 @default.
• W4308354355 hasConcept C188816634 @default.
• W4308354355 hasConcept C203092338 @default.
• W4308354355 hasConcept C535046627 @default.
• W4308354355 hasConcept C71924100 @default.
• W4308354355 hasConcept C72563966 @default.
• W4308354355 hasConceptScore W4308354355C126322002 @default.
• W4308354355 hasConceptScore W4308354355C12770488 @default.
• W4308354355 hasConceptScore W4308354355C141071460 @default.
• W4308354355 hasConceptScore W4308354355C143998085 @default.
• W4308354355 hasConceptScore W4308354355C188816634 @default.
• W4308354355 hasConceptScore W4308354355C203092338 @default.
• W4308354355 hasConceptScore W4308354355C535046627 @default.
• W4308354355 hasConceptScore W4308354355C71924100 @default.
• W4308354355 hasConceptScore W4308354355C72563966 @default.
• W4308354355 hasIssue "1" @default.
• W4308354355 hasLocation W43083543551 @default.
• W4308354355 hasLocation W43083543552 @default.
• W4308354355 hasLocation W43083543553 @default.

• next